CClinicalTrials.gg
CompletedNCT06392802Updated Sep 3, 2026

Effectiveness of a Rehabilitation Exercise Plan at Home to Treat Post-stroke Patients in the Chronic Phase

An interventional study of Rehabilitation treatment using Muvity in Stroke, Motor Disorders and Physical Disability, sponsored by Universitat Politècnica de Catalunya. Completed at 2 sites in Spain. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Universitat Politècnica de Catalunya · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Mar 2023, registered Jan 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
39
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Background: Stroke is the second leading cause of death worldwide and the primary medical cause of disability. It is estimated that 45% of affected individuals will continue to have moderate or severe functional disabilities throughout their lives. According to the American Stroke Association, telerehabilitation has the potential to provide timely and efficient care to stroke survivors, improving patients' functional outcomes while reducing long-term disability and associated costs.

Hypothesis: Through the developed application (Muvity), the study aims to contribute to the validity of telerehabilitation and virtual reality as beneficial tools for rehabilitation, specifically for individuals in the post-stroke sequelae phase.

Objectives: To evaluate the effectiveness of a non-immersive virtual reality program in telerehabilitation for patients who have experienced a stroke more than 6 months ago.

Methodology: Prospective longitudinal study with single blinding. The control group undergoes a conventional intervention, while the experimental group undergoes an innovative intervention (n=25).

Variables: The collected variables and measurement tools include upper extremity functionality (Fugl-Meyer scale), balance (Berg), functional independence (Barthel), pain (Brief Pain Inventory), post-stroke quality of life (ECVI-38), emotional health (UCLA Self-Rating Depression Scale), treatment expectations (Expectation for Treatment Scale), treatment adherence (through an APP), and satisfaction (Telehealth Usability Questionnaire).

Statistical Analysis: Data will be analyzed per protocol (PP); the normality distribution of the data will be assessed, and results will be analyzed using parametric or non-parametric techniques depending on normality. A bivariate analysis will compare results between the control and intervention groups, considering a statistically significant result when p \< 0.05.

Expected Results: Similar results are expected between groups or slightly favorable outcomes in the experimental group for the different variables.

Applicability and Relevance: The application would facilitate access to motor rehabilitation treatments in an enjoyable and engaging manner, promoting physical activity and contributing to a healthy lifestyle. Upon obtaining the results of this study, a trial implementation of the application in five socio-sanitary or associative centers is planned to verify its final applicability.

Read the detailed description

As described in the "Catalan Consensus on Evaluation and Treatment of Post-Stroke Patients," in the chronic phase when the effects of stroke have stabilized, patients should continue to have access to rehabilitation services to address their long-term needs. However, the decision to refer patients to rehabilitation services often relies heavily on patient and family demand, lacking clear criteria to ensure coordination between Primary Care services and specialized ones. Considering this gap in action, along with the estimated high costs associated with caring for stroke survivors, non-immersive virtual reality telerehabilitation is proposed as a beneficial tool for both patients and healthcare professionals and managers.

The study aims to contribute to the validity of telerehabilitation and virtual reality as beneficial tools for rehabilitation, specifically for individuals experiencing post-stroke sequelae.

Objectives (General and Specific)

The general objective of this study is to evaluate the effectiveness of a non-immersive virtual reality program in telerehabilitation targeting subjects who have suffered a stroke for more than six months, comparing the effectiveness of conventional therapy with gamified therapy (using the developed computational application).

The specific objectives of the study are as follows:

  • Observe changes in joint range of motion (flexion, abduction, horizontal abduction of the shoulder, and elbow flexion) before and after the intervention.
  • Assess if game performance (scores, time, etc.) changes between week 2 and week 12.
  • Analyze the effects of the computational application on users' balance. Compare balance results between both groups.
  • Measure the evolution of the pain variable before and after the intervention and compare it between the two groups.
  • Explore potential changes in users' emotional health throughout the intervention.
  • Determine the impact of the application on the user's quality of life (QoL).
  • Verify if subjects' expectations are met through the application's use.
  • Compare treatment adherence using the application versus conventional methodology.
  • Determine if using the application leads to greater satisfaction in offering home rehabilitation guidance.
02

Conditions studied

  • Stroke
  • Motor Disorders
  • Physical Disability

Keywords

  • post-stroke
  • telerehabilitation
  • non-immersive virtual reality
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 39 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Universitat Politècnica de Catalunya is the lead sponsor of 11 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age: between 18 and 85 years old.
  • Stroke duration of more than six months + Discharge from post-stroke rehabilitation.
  • Moderate physical disability: scoring between 1-3 on the Modified Rankin Scale.
  • Standing: able to stand safely for 2 minutes without support (maximum score -4- on item 2 of the Berg Scale).
  • Vision: capable of correctly visualizing a screen at a distance of 2 meters.
  • Cognitive status: No cognitive impairment or mild cognitive impairment (Mini-Mental State Examination score ≥ 24). Ability to understand and follow verbal instructions in Catalan or Spanish.
  • Technological skills: capable of basic use of a mobile phone and computer (keyboard, mouse, screen).
  • Glenohumeral joint mobility: minimum of 30º flexion, abduction, horizontal abduction; and 15º internal and external rotation.
  • Elbow joint mobility: minimum of 45º flexion.

Exclusion criteria

Exclusion Criteria:

  • Engaging in intense physical therapies.
  • Severe aphasia: inability or difficulty communicating through speech.
  • Cognitive impairments affecting short and mid-term memory.
  • Vision: having visual deficits in either eye that may impair screen visualization.
  • Vision: experiencing hemispatial neglect, meaning difficulty processing stimuli on the side opposite to the injury.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Investigator)
Enrollment
39 participants (actual)

Study arms

  • No intervention
    Control

    This group follows a treatment similar to the one that a public hospital recommends. They receive a sheet of paper with the description of some exercises to do at home. These should be done in three 30-min-sessions per week, during 12 weeks.

  • Experimental
    Muvity - Intervention

    This group follows a treatment prescribed by a therapist using Muvity, a telerehabilitation system using a depth camera. The treatment consists of some exercises guided by a virtual avatar, and some exergames to play. The computer application monitors the ranges of motion of joint angles as well as time played and deviations from theoretical trajectories. These sessions are programmed to be done in three 30-min-sessions per week, during 12 weeks (same amount as the Control group).

    Device: Rehabilitation treatment using Muvity

Interventions

  • DeviceRehabilitation treatment using Muvity

    The users have the support of the telerehabilitation system Muvity

06

What researchers measure

Primary outcomes

  1. Fugl-Meyer

    Standard Fugl-Meyer score to assess motor functionality. Sections A (upper limbs, up to 36 points), D (coordination, up to 6 points), H (sensation, up to 6 points), I (joint movement (up to 16 points), and J (joint pain, up to 16 points). The total score could be up to 80 points (the higher score, the higher functionality).

    Time frame: Within one week before and within one week after the treatments for both groups.

  2. Berg score

    The Standard Berg Balance Scale is used to assess balance control. Scores range from 0 (equilibrium heavily affected) to 56 (excellent equilibrium capacity).

    Time frame: Within one week before and within one week after the treatments for both groups.

  3. Brief Pain Inventory

    Standard score to assess joint pain. It consists of 11 questions related to pain intensity. A score of 0 indicates pain absence, and 10 high pain intensity.

    Time frame: Within one week before and within one week after the treatments for both groups.

  4. Ranges of motion

    The ranges of motion of upper and lower limb joint angles are computed before and after the treatments for both control and intervention groups during the assessment face-to-face sessions. This information is also gathered for the intervention group during the 12-week treatment.

    Time frame: Within one week before and within one week after the treatment for both groups and during the 12-week treatment for the intervention group.

Secondary outcomes

  1. Ranges of motion

    The ranges of motion of upper and lower limb joint angles are computed before and after the treatments for both control and intervention groups during the assessment face-to-face sessions. This information is also gathered for the intervention group during the 12-week treatment

    Time frame: During the 12-week treatment for the intervention group.

  2. Time spent for the rehabilitation sessions

    The time spent for the rehabilitation sessions is monitored for both groups (by a simple mobile app for the Control group and by Muvity for the intervention group)

    Time frame: During the 12-week treatment for the intervention group.

  3. ECVI-38

    Quality of life is monitored by the standard test ECVI-38. This stands for "Escala de calidad de vida para el ictus" (ECVI) in Spanish (Quality of Life Scale for Stroke), It ranges between 0 (no impairment) to 100 (maximum impairment).

    Time frame: Within one week before and within one week after the 12-week treatment

  4. UCLA Self-Rating Depression Scale

    Self-rating depression score. It ranges between 3 (low perception of loneliness) to 9 (high perception of loneliness).

    Time frame: Within one week before and within one week after the 12-week treatment

07

Study locations

2 sites
  • Universitat Politècnica de Catalunya
    Barcelona, Barcelona 08019, Spain
  • Associació Disminuïts Físics d'Osona
    Vic, Barcelona 08500, Spain
08

References and documents

Individual participant data

Plan to share: No — We aim to disseminate the aggregated results. The identification of each participant will not be possible for the researchers who will use these data.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06392802
Lead sponsor
Universitat Politècnica de Catalunya
Collaborators
Consorci Hospitalari de Vic, Institut Català de la Salut, EAP Vic (CAP Remei), Associació Disminuïts Físics d'Osona
Responsible party
Gil Serrancolí (Principal Investigator, Universitat Politècnica de Catalunya) — Principal investigator
First posted
Apr 30, 2024
Start date
Mar 1, 2023
Primary completion
Feb 28, 2025
Completion
Apr 30, 2025
Last update
Sep 3, 2026

Study contacts

Gil Serrancolí, PhD
principal investigator · Universitat Politècnica de Catalunya
Cris Molas, Msc
principal investigator · Associació Disminuïts Físics d'Osona

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion